Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 889865-38-7 | MDL No. : | MFCD16294419 |
Formula : | C17H25BO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZIKLUMIQYINQLY-UHFFFAOYSA-N |
M.W : | 304.19 | Pubchem ID : | 58005653 |
Synonyms : |
|
Num. heavy atoms : | 22 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.65 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 87.61 |
TPSA : | 36.92 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.5 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.74 |
Log Po/w (WLOGP) : | 2.89 |
Log Po/w (MLOGP) : | 1.97 |
Log Po/w (SILICOS-IT) : | 2.45 |
Consensus Log Po/w : | 2.21 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.09 |
Solubility : | 0.025 mg/ml ; 0.000082 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.21 |
Solubility : | 0.0189 mg/ml ; 0.000062 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.62 |
Solubility : | 0.00726 mg/ml ; 0.0000239 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 4.05 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With potassium acetate; dimethyl sulfoxide In water | 1) Production of 4-(4,4,5,5-tetramethyl-1,3,2-dioxoborolan-2-yl)-1-(2-tetrahydropyranyloxy)benzene: Potassium acetate (5.8 g, 59.2 mmol) and bis(diphenylphosphino)ferrocene palladium(II) dichloride-dichloromethane (806 mg, 0.99 mmol) were added to a dimethyl sulfoxide (70 mL) solution of 4-iodophenol tetrahydropyranyl ether (6.0 g, 19.7 mmol) readily preparable from 4-iodophenol and dihydropyran, and bis(pinacolato)diboron (6.01 g, 23.7 mmol), and stirred in a nitrogen atmosphere at 75°C for 1 hour. The reaction mixture was cooled to room temperature, water was added to it, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried with anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified through silica gel column chromatography (C-300, hexane/ethyl acetate = 8/1) to obtain the entitled compound (4.54 g, 76 percent). |
[ 850568-69-3 ]
4,4,5,5-tetramethyl-2-(3-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.99
[ 850411-08-4 ]
2-(3-((1,3-Dioxolan-2-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.86
[ 251566-01-5 ]
2-[4-(2-Ethyl-hexyloxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
Similarity: 0.85
[ 1174548-77-6 ]
4,4,5,5-Tetramethyl-2-(4-(pentyloxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.85
[ 921937-76-0 ]
2-[4-(Hexyloxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.85
[ 850568-69-3 ]
4,4,5,5-tetramethyl-2-(3-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.99
[ 850411-08-4 ]
2-(3-((1,3-Dioxolan-2-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.86
[ 251566-01-5 ]
2-[4-(2-Ethyl-hexyloxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
Similarity: 0.85
[ 1174548-77-6 ]
4,4,5,5-Tetramethyl-2-(4-(pentyloxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.85
[ 921937-76-0 ]
2-[4-(Hexyloxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.85
[ 850568-69-3 ]
4,4,5,5-tetramethyl-2-(3-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.99
[ 850411-08-4 ]
2-(3-((1,3-Dioxolan-2-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.86
[ 251566-01-5 ]
2-[4-(2-Ethyl-hexyloxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
Similarity: 0.85
[ 1174548-77-6 ]
4,4,5,5-Tetramethyl-2-(4-(pentyloxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.85
[ 921937-76-0 ]
2-[4-(Hexyloxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.85
[ 850568-69-3 ]
4,4,5,5-tetramethyl-2-(3-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane
Similarity: 0.99
[ 182281-01-2 ]
(4-((Tetrahydro-2H-pyran-2-yl)oxy)phenyl)boronic acid
Similarity: 0.74
[ 1287777-05-2 ]
3-[(2-Tetrahydropyranyl)oxy]phenylboronic Acid
Similarity: 0.72
[ 1292317-54-4 ]
2-((Tetrahydro-2H-pyran-4-yl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
Similarity: 0.71